InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (0 oper.)
▼ Ventas (2 oper.)
Historial del iniciado
Director GeneralCompras declaradas
0
Ventas declaradas
2
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the full record of transactions filed by Quart Barry D, Director General. Director active across 4 companies, notably Heron Therapeutics, INC.. Cumulatively, 20 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €859k. History available since 30 April 2021. The latest transaction was disclosed on 19 August 2026 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Quart Barry D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones20 en total
2600 títulos0Class A Ordinary ShareSEC:0001384243-26-000014:0
13.099 títulos@ 14,33 US$1.94% mcap22.2% de su flujoClass A Ordinary ShareSEC:0001384243-26-000010:0
13.099 títulos@ 50,10 US$6.77% mcap77.8% de su flujoClass A Ordinary ShareSEC:0001384243-26-000010:1
6901 títulos@ 14,33 US$7.8% de su flujoClass A Ordinary ShareSEC:0001384243-26-000008:0
6901 títulos@ 50,00 US$27.1% de su flujoClass A Ordinary ShareSEC:0001384243-26-000008:1
110 títulos@ 15,47 US$0.1% de su flujoClass A Ordinary ShareSEC:0001384243-26-000004:0
830 títulos@ 15,47 US$0.8% de su flujoClass A Ordinary ShareSEC:0001384243-26-000002:0
20.129 títulos@ 10,36 US$13.6% de su flujoClass A Ordinary ShareSEC:0001384243-25-000004:0
6900 títulos@ 3,80 US$2.0% de su flujoClass A Ordinary ShareSEC:0001415889-25-016724:0
3173 títulosClass A Ordinary ShareSEC:0001415889-25-015784:0
4373 títulosClass A Common ShareSEC:0001415889-24-015994:0
5000 títulosClass A Common ShareSEC:0001415889-23-010559:0
1655 títulos@ 3,2725 US$49.7% de su flujoCommon StockSEC:0001209191-23-003563:0
21.959 títulos@ 1,59 US$100.0% de su flujoClass A Common ShareSEC:0001415889-22-011878:0
3646 títulosCommon StockSEC:0001209191-22-053835:0
1504 títulos@ 3,842 US$50.3% de su flujoCommon StockSEC:0001209191-22-042262:0
3646 títulosCommon StockSEC:0001209191-22-024522:0
3646 títulosCommon StockSEC:0001209191-22-003362:0
3646 títulosCommon StockSEC:0001209191-21-060551:0
1529 títulos@ 13,8975 US$100.0% de su flujoCommon StockSEC:0001209191-21-046790:0
20 de 20 declaraciones
About Quart Barry D
Quart Barry D is Chief Executive Officer and is associated with Kiniksa Pharmaceuticals International, plc, Heron Therapeutics, INC., Kiniksa Pharmaceuticals, Ltd. and HERON THERAPEUTICS, INC. /DE/. Across 19 filings in total, the 19 sampled filings cover the period from 2021-07-15 to 2026-04-29 and show EUR 0 of purchases and EUR 859024 of sales, with Levée d'options as the most frequent transaction nature.
